Eric Thompson Email & Phone Number

Glendale, AZ, US

Phoenix, Arizona Area

Precision Biosolutions consults on a broad range of precision medicine needs. I have expertise in biomarker strategy for new and existing treatments, evidence based medicine, knowledge management/organization, reimbursement in molecular pathology, translational science, translational medicine, bringing biomarker tests to market and more. Please contact me.

Phoenix, Arizona Area

Formed and direct evidence based medicine group responsible for the content of a molecular tumor profiling product. Worked with a university to establish an evidence based medicine review of genetic testing for a payer. Established molecular pathology database for evidence group. Lead interdisciplinary evidence review board. Instrumental in the development.

Phoenix, Arizona Area

Formed and direct evidence based medicine group responsible for the content of a molecular tumor profiling product. Established molecular pathology database for evidence group. Lead interdisciplinary evidence review board. Instrumental in the development of the LIMS system utilized to generate the patient reports for ordering physicians. Part of patient.

Phoenix, Arizona Area

Worked with consortium including IGC, Arizona State University and The Critical Path Institute to establishing the framework for National Biomarker Development Alliance, now lead by Arizona State University.Wrote initial draft of launch plan, budget, reimbursement plan, evidence based medicine framework to enable the successful launch of Paradigm.

I shared responsibility for the direction of the Predictive Safety Testing Consortium (PSTC), a unique public-private partnership, led by the non-profit Critical Path Institute (C-Path), that brings together pharmaceutical companies to share and qualify safety testing methods under advisement of the Food and Drug Administration ("FDA") and its European.

I directed a team of scientists gathering information on predictive biomarkers. We then converted this information into the rules that drive the clinical reports in Caris' tumor profiling products.

I worked on the Target Now program validating biomarkers and helping evaluate new biomarkers to add to Caris' clinical molecular profiling service.

I worked on the Cancer Erradication program. This is a project to develop a preventive cancer vaccine. I was involved in target validation using various cellular immunology assays. These include ELISpot, MHC I binding assays and generating CTL to targets. Previously I developed a method for screening cells on a novel peptide microarray in order to identify.

Postdoctoral training in biochemistry, molecular and cellular biology. The project related to the potential function of Mucin 1 or MUC1 in carcinogenesis.